Your browser doesn't support javascript.
loading
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS).
Coates, Laura C; Gossec, Laure; Theander, Elke; Bergmans, Paul; Neuhold, Marlies; Karyekar, Chetan S; Shawi, May; Noël, Wim; Schett, Georg; McInnes, Iain B.
Afiliação
  • Coates LC; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK laura.coates@ndorms.ox.ac.uk.
  • Gossec L; INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Universite, Paris, France.
  • Theander E; APHP, Rheumatology Department, Hopital Universitaire Pitie Salpetriere, Paris, France.
  • Bergmans P; Janssen Scientific Affairs, LLC, Solna, Sweden.
  • Neuhold M; Janssen, Breda, The Netherlands.
  • Karyekar CS; Janssen Scientific Affairs, LLC, Brussels, Belgium.
  • Shawi M; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA.
  • Noël W; Immunology Global Medical Affairs, Janssen Pharmaceutical Companies of Johnson & Johnson, Horsham, Pennsylvania, USA.
  • Schett G; Janssen Scientific Affairs, LLC, Brussels, Belgium.
  • McInnes IB; Rheumatology, University of Erlangen, Erlangen, Germany.
Ann Rheum Dis ; 81(3): 359-369, 2022 03.
Article em En | MEDLINE | ID: mdl-34819273

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Antirreumáticos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Psoriásica / Antirreumáticos / Anticorpos Monoclonais Humanizados Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article